全文获取类型
收费全文 | 3652篇 |
免费 | 180篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 37篇 |
妇产科学 | 55篇 |
基础医学 | 404篇 |
口腔科学 | 107篇 |
临床医学 | 219篇 |
内科学 | 913篇 |
皮肤病学 | 108篇 |
神经病学 | 337篇 |
特种医学 | 209篇 |
外科学 | 662篇 |
综合类 | 18篇 |
预防医学 | 124篇 |
眼科学 | 69篇 |
药学 | 195篇 |
中国医学 | 10篇 |
肿瘤学 | 365篇 |
出版年
2023年 | 36篇 |
2022年 | 78篇 |
2021年 | 127篇 |
2020年 | 55篇 |
2019年 | 53篇 |
2018年 | 109篇 |
2017年 | 66篇 |
2016年 | 93篇 |
2015年 | 89篇 |
2014年 | 127篇 |
2013年 | 142篇 |
2012年 | 242篇 |
2011年 | 222篇 |
2010年 | 109篇 |
2009年 | 106篇 |
2008年 | 180篇 |
2007年 | 205篇 |
2006年 | 166篇 |
2005年 | 202篇 |
2004年 | 158篇 |
2003年 | 184篇 |
2002年 | 160篇 |
2001年 | 66篇 |
2000年 | 62篇 |
1999年 | 65篇 |
1998年 | 43篇 |
1997年 | 38篇 |
1996年 | 30篇 |
1995年 | 27篇 |
1994年 | 25篇 |
1993年 | 22篇 |
1992年 | 49篇 |
1991年 | 50篇 |
1990年 | 35篇 |
1989年 | 53篇 |
1988年 | 49篇 |
1987年 | 61篇 |
1986年 | 43篇 |
1985年 | 36篇 |
1984年 | 31篇 |
1983年 | 16篇 |
1981年 | 8篇 |
1980年 | 12篇 |
1979年 | 19篇 |
1978年 | 14篇 |
1977年 | 11篇 |
1976年 | 9篇 |
1974年 | 8篇 |
1970年 | 8篇 |
1966年 | 9篇 |
排序方式: 共有3852条查询结果,搜索用时 15 毫秒
71.
Hiroyuki Inoue Atsushi Shiozaki Hitoshi Fujiwara Hirotaka Konishi Jun Kiuchi Takuma Ohashi Hiroki Shimizu Tomohiro Arita Yusuke Yamamoto Ryo Morimura Yoshiaki Kuriu Hisashi Ikoma Takeshi Kubota Kazuma Okamoto Eigo Otsuji 《Oncology Letters》2022,24(2)
Predicting the prognosis and adverse events (AEs) of nivolumab therapy for recurrent esophageal cancer is very important. The present study investigated whether a simple blood biochemical examination could be used to predict prognosis and AEs following nivolumab treatment for relapse of esophageal cancer. A total of 41 patients who received nivolumab treatment for recurrent esophageal cancer after esophagectomy were analyzed. The absolute lymphocyte count (ALC), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), monocyte-lymphocyte ratio (MLR) and C-reactive protein-albumin ratio (CAR) were assessed at the time of nivolumab induction as indices that can be calculated by blood biochemical examinations alone. Median values were 1,015 for ALC, 3.401 for NLR, 242.6 for PLR, 0.458 for MLR and 0.119 for CAR, and patients were divided into two groups according to values. A high ALC, low NLR, low PLR, low MLR and low CAR were associated with a better response to nivolumab. In addition, patients with the aforementioned indices, with the exception of low PLR, or better response were more likely to develop AEs in univariate analysis. In multivariate analysis, a high ALC [odds ratio (OR): 4.857, P=0.043] and low CAR (OR: 9.099, P=0.004) were identified as independent risk factors for AEs. Survival analysis revealed that overall survival and progression-free survival (PFS) rates after nivolumab treatment differed significantly between the high and low groups of ALC, NLR, PLR, MLR and CAR. The multivariate analysis identified a low ALC [hazard ratio (HR): 3.710, P=0.003] and high CAR (HR: 2.953, P=0.007) as independent poor prognostic factors of PFS. In conclusion, ALC and CAR have potential as biomarkers for outcomes of recurrent esophageal cancer following nivolumab treatment. 相似文献
72.
Kenichi Shikata Sadayoshi Ito Naoki Kashihara Masaomi Nangaku Takashi Wada Yasuyuki Okuda Tomoko Sawanobori Kotaro Sugimoto 《Journal of diabetes investigation.》2022,13(7):1190
Aims/IntroductionWe evaluated the effect of co‐administration of esaxerenone and a sodium–glucose cotransporter 2 (SGLT2) inhibitor on the magnitude of serum potassium elevation in Japanese patients with diabetic kidney disease.Materials and MethodsWe carried out a prespecified subanalysis of data from two phase III studies: a multicenter, randomized, double‐blind, placebo‐controlled trial in patients with type 2 diabetes and microalbuminuria (J308); and a multicenter, single‐arm, open‐label trial in patients with type 2 diabetes and macroalbuminuria (J309). Changes in serum potassium levels during the studies and other measures were evaluated according to SGLT2 inhibitor use.ResultsIn both studies, time‐course changes in serum potassium levels, and incidence rates of serum potassium elevation were lower in patients with co‐administration of SGLT2 inhibitor in both the placebo and esaxerenone groups than those without the inhibitor. In contrast, time‐course changes and mean percentage changes from baseline in urinary albumin‐to‐creatinine ratio, the proportion of patients with albuminuria remission and time‐course changes in blood pressure did not change with or without SGLT2 inhibitor, whereas the albumin‐to‐creatinine ratio and blood pressure were reduced with esaxerenone. The blood glucose‐lowering effect of SGLT2 inhibitor was not affected by esaxerenone.ConclusionsIn Japanese patients with type 2 diabetes and albuminuria treated with esaxerenone, concomitant use of SGLT2 inhibitor reduced the magnitude of serum potassium elevation without any change of its antihypertensive and albuminuria‐suppressing effects. Co‐administration of esaxerenone and SGLT2 inhibitor might be a beneficial treatment option for patients with diabetic kidney disease. 相似文献
73.
74.
75.
76.
77.
Diagnostic and clinical role of serum proteinase 3 antineutrophil cytoplasmic antibodies in inflammatory bowel disease
下载免费PDF全文
![点击此处可从《Journal of gastroenterology and hepatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
78.
Self‐expanding metallic stent improves histopathological edema compared with transanal drainage tube for malignant colorectal obstruction
下载免费PDF全文
![点击此处可从《Digestive endoscopy》网站下载免费的PDF全文](/ch/ext_images/free.gif)
79.
Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction
Purpose
To evaluate the efficacy and safety of intense pulsed light (IPL) combined with meibomian gland expression (MGX) for treatment of refractory meibomian gland dysfunction (MGD).Methods
Ninety eyes of 45 patients were randomly assigned to receive either the combination of IPL and MGX or MGX alone (control). Each eye underwent eight treatment sessions at 3-week intervals. Parameters were evaluated before and during treatment as well as at 3–11 weeks after the last treatment session. Measured parameters included the Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire score, noninvasive breakup time (NIBUT), fluorescein breakup time (BUT), lipid layer grade, lipid layer thickness (LLT), lid margin abnormalities, corneal and conjunctival fluorescein staining (CFS) score, meibum grade, and meiboscore.Results
A significant improvement in lipid layer grade was apparent in the IPL-MGX group from 6 to 32 weeks after treatment onset (adjusted P?<?0.001) but was not observed in the control group. The IPL-MGX group also showed significant improvements in LLT, NIBUT, BUT, lid margin abnormalities, and meibum grade compared with the control group at 24 and 32 weeks (adjusted P?<?0.001) as well as significant improvements in the SPEED score at 32 weeks (adjusted P?=?0.044) and in CFS score at 24 (adjusted P?=?0.015) and 32 (adjusted P?=?0.006) weeks.Conclusions
The combination of IPL and MGX improved homeostasis of the tear film and ameliorated ocular symptoms in patients with refractory MGD and is thus a promising modality for treatment of this condition. 相似文献80.
Tetsuro Ohba Hiroki Oba Kensuke Koyama Kotaro Oda Nobuki Tanaka Koji Fujita Hirotaka Haro 《Journal of orthopaedic science》2021,26(4):678-683
BackgroundLocomotive syndrome (LS) was proposed by the Japanese Orthopedic Association and refers to a scenario in which imminent future nursing care services will be required by elderly adults to manage the functional deterioration of their locomotive organs. It is a social imperative to clarify the risk factors and treatment strategy for LS. However, the relationship between LS and adult spinal deformity (ASD) in those who are treated with spinal corrective surgery remains largely unknown.MethodsForty consecutive patients who had ASD and underwent spinal surgery for their disorder were included in this study. Locomotive dysfunction was evaluated using the 25-item Geriatric Locomotive Function Scale-25 (GLFS-25) questionnaire and physical performance tests including the one-legged standing test, the two-step test, the stand-up test, the handgrip strength, and gait speed test which were measured preoperatively, 6 months after surgery, and 1 year after surgery.ResultsOf the patients with ASD treated surgically, 95% of them had LS preoperatively and LS prevalence decreased significantly 1 year after surgery by 67.5% compared with the preoperative rate. Among physical performance tests, the walking stride and one-legged standing test improved significantly after spinal corrective surgery. The GLFS-25 items for the domains of pain, mobility, and domestic life improved overall postoperatively, whereas items in the self-care domain did not and the item for difficulty in putting on and taking off trousers and pants worsened.ConclusionsSpinal corrective surgery significantly improved physical performance tests as well as the frequency and severity of LS in patients with ASD. However, some GLFS-25 items can worsen after surgery and require attention. 相似文献